Rua Bioscience Limited logo

Capital Change Notice - Employee allocation

Capital Change19 September 2025RUAHealthcare

Capital Change Notice




Section 1: Issuer information

Name of issuer Rua Bioscience Limited

NZX ticker code RUA

Class of financial product Ordinary shares

ISIN (If unknown, check on NZX website) NZRUAE0004S1

Currency NZ$

Section 2: Capital change details

Number issued/acquired/redeemed 3,594,037 ordinary shares

Nominal value (if any) N/A

Issue/acquisition/redemption price per security $0.00

Nature of the payment (for example, cash or other

consideration)

Zero cash – provision of

performance payments to

employees

Amount paid up (if not in full) N/A


Percentage of total class of Financial Products

issued/acquired/redeemed/ (calculated on the number of

Financial Products of the Class, excluding any Treasury Stock,

in existence)

1


Rua currently has 240,448,011

ordinary shares on issue and

5,926,673 warrants on issue.

This issue of ordinary shares

represents 1.44% of the total

ordinary shares plus warrants

on issue (being the percentage

should all warrants vest and be

exercised).

For an issue of Convertible Financial Products or Options, the

principal terms of Conversion (for example the Conversion

price and Conversion date and the ranking of the Financial

Product in relation to other Classes of Financial Product) or the

Option (for example, the exercise price and exercise date)

N/A

Reason for issue/acquisition/redemption and specific authority

for issue/acquisition/redemption/ (the reason for change must

be identified here)

Placement of new ordinary

shares to reward staff for past

performance and incentivise

future performance.

Total number of Financial Products of the Class after the

issue/acquisition/redemption/Conversion (excluding Treasury

Stock) and the total number of Financial Products of the Class

held as Treasury Stock after the issue/acquisition/redemption.

Total ordinary shares on issue:

244,042,048 ordinary shares

Total warrants on issue:

5,926,673 warrants

In the case of an acquisition of shares, whether those shares

are to be held as treasury stock

N/A

Specific authority for the issue, acquisition, or redemption,

including a reference to the rule pursuant to which the issue,

acquisition, or redemption is made

Board resolution and Listing

Rule 4.6.1


1

The percentage is to be calculated immediately before the issue, acquisition, redemption or Conversion.

Terms or details of the issue, acquisition, or redemption (for
example: restrictions, escrow arrangements)

Issue of ordinary shares which

rank equally with all other fully

paid ordinary shares

Date of issue/acquisition/redemption 19/9/2025

Section 3: Authority for this announcement and contact person

Name of person


authorised to make this announcement Paul Naske

Contact person for this announcement Paul Naske

Contact phone number 021 445 154

Contact email address Paul.naske@ruabio.com

Date of release through MAP


19/09/2025

Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.